Glutaminase-IN-3

CAS No. 1439399-45-7

Glutaminase-IN-3( —— )

Catalog No. M34941 CAS No. 1439399-45-7

Glutaminase-IN-3 is a potent Glutaminase 1 inhibitor with potential antitumor activity and inhibits GLS1 for cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 54 Get Quote
10MG 77 Get Quote
25MG 118 Get Quote
50MG 174 Get Quote
100MG 251 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Glutaminase-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    Glutaminase-IN-3 is a potent Glutaminase 1 inhibitor with potential antitumor activity and inhibits GLS1 for cancer research.
  • Description
    Glutaminase-IN-3 (compound 657) is a potent glutaminase inhibitor with an IC50 of 0.24 μM for Glutaminase 1 (GLS1). Glutaminase-IN-3 is extracted from patent WO2014089048A1, compound 657.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Glutaminase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1439399-45-7
  • Formula Weight
    452.45
  • Molecular Formula
    C19H19F3N6O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (110.51 mM; Ultrasonic )
  • SMILES
    FC(F)(F)Oc1cccc(CC(=O)N=c2ccc(CCCCc3n[nH]c(=N)s3)n[nH]2)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Mark K. Bennett, et al. Treatment of cancer with heterocyclic inhibitors of glutaminase. WO2014089048A1.
molnova catalog
related products
  • PIN1 inhibitor API-1

    PIN1 inhibitor API-1 is a specific Pin1 inhibitor (IC50: 72.3 nM). PIN1 inhibitor API-1 retains the active conformation of pXPO5 and restores the ability of pXPO5 to transport pre-miRNAs from the nucleus to cytoplasm, thus up-regulating the anticancer miRNA biogenesis to suppress both in vitro and in vivo hepatocellular carcinoma development.

  • HPV-E6-C

    HPV-E6-C

  • DiZPK

    DiZPK is an analog of pyrrolysine and acts as a photocrosslinker.